Advertisement
The live presentation takes place Thursday, September 25, 2008 at10:00 a.m. Eastern Time (ET) /7:00 a.m. Pacific Time (PT). The presentationwill be simultaneously webcast and may be accessed on the Company's website athttp://www.neurocrine.com which will link you to the UBS Conference site.Once you have been linked to their site, you have the option to search bycompany name, or by time and date to access the webcast.
Advertisement
If you are unable to attend the webcast and would like further informationon this announcement please contact the Investor Relations Department atNeurocrine Biosciences at (858) 617-7600. Viewers are encouraged to visit thewebsite approximately 5 minutes prior to the presentation to download orinstall any necessary software. A replay of the presentation will be availableapproximately three hours after the conclusion of the live event and will bearchived on the website for two weeks.
About Neurocrine
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused onneurological and endocrine diseases and disorders. Our product candidatesaddress some of the largest pharmaceutical markets in the world includingendometriosis, irritable bowel syndrome (IBS), anxiety, depression, pain,diabetes, benign prostatic hyperplasia (BPH) and other neurological andendocrine related diseases and disorders. Neurocrine Biosciences, Inc. newsreleases are available through the Company's website via the internet athttp://www.neurocrine.com
SOURCE Neurocrine Biosciences, Inc.
